π Tender Overview
Project Number
48389
Company Name
NSIA Advanced Medical Services Limited
Date ESRS Disclosed
Feb 27, 2025
Country
Nigeria
Region
Africa
Last Updated Date
Environmental Category
B
Status
Pending Approval
Sector
other
Industry
other
Department
Regional Industry - MAS Africa
Project Description
The proposed investment is an A-Loan of up to US$24.3million (in Naira equivalent) to support NSIA Advanced Medical Services Limited ( Medserve ), to expand and roll-out medical diagnostic and treatment centers, across 13 states in Nigeria (the Project ). The A-loan is aimed at financing the first phase of Medserveβs expansion which will comprise 13 new healthcare diagnostic centers, 2 Oncology centers, and 3 Catheterization (Cath) Labs. The centers offer radiology and diagnostic imaging services with the possibility of Chemotherapy..
Medserve is a company wholly owned by the sovereign wealth fund of Nigeria, Nigeria Sovereign Investment Authority ( NSIA or the Fund), through its healthcare platform company, NSIA Healthcare Development and Investment Company ( NHDIC ). It was newly established to house and expand NSIAβs diagnostics and cancer treatment healthcare business, following a successful pilot of one oncology center and two diagnostic centers in Nigeria.
All three existing and operational centers in the current three locations operate within the premises of government teaching hospitals and share basic amenities of the host institutions, e.g. water sourcing and wastewater utility network.
Overview of IFC's Scope of Review
IFCβs environmental and social (E&S) review of this project consisted of an analysis of the clientβs E&S Management System (ESMS) and relevant information, including policies, codes of conduct, and management standards and procedures. The review also included a field visit to Kaduna site, Kano diagnostic center and Lagos university teaching hospital cancer center operational sites in Nigeria and meetings with key staff (including environment, social and governance (ESG) department head and team, operational manager and HR head) in April 2024.